Last reviewed · How we verify

NCT04554264: DEPARTS

Complicated Grief in ICU in the Aftermath of COVID-19

Withdrawn NA Last updated 23 March 2023
What this trial tests

NA trial testing questionnaire in Complicated Grief. Withdrawn.

Timeline
1 September 2020
Primary endpoint
1 September 2021
1 September 2022

Quick facts

Lead sponsorCentre Hospitalier Universitaire, Amiens
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposesupportive care
Start date1 September 2020
Primary completion1 September 2021
Estimated completion1 September 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

18 and older, any sex, with Complicated Grief or Intensive Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An increased proportion of deaths occur in the intensive care unit (ICU). Some amenable factors such as end-of-life practices may contribute to complicated grief. Because of the COVID-19 pandemic, visitor restrictions in health care facilities have been implemented. Families were also unable to implement usual funerals. The investigators hypothesize that these policies and practices may impact grief during covid-19 pandemic. The aim of this study is to evaluate the prevalence of complicated grief after death of a relative in the ICU during the COVID-19 pandemic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of questionnaire

Trials testing the same drug.

Other recruiting trials for Complicated Grief

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04554264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing